Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Neuroendocrine Cancer - New neuroendocrine cancer research from M.H. Kulke and colleagues discussed
Non-Small Cell Lung Cancer - Recent findings in non-small cell lung cancer described by researchers from University of Turin
Prostate Cancer - Studies from University of Montreal yield new information about prostate cancer
Prostate Cancer - Studies in the area of prostate cancer reported from University College
Prostatectomy - Study findings on prostatectomy are outlined in reports from C. Cozzarini and colleagues
Pulmonary Hypertension - Study data from Bayer HealthCare update knowledge of pulmonary hypertension
Schizophrenia - Scientists at University of Colorado target schizophrenia
Transdermal Delivery - Research results from H.J. Aubin and colleagues update understanding of transdermal delivery
Atopic Dermatitis Animal Studies - New atopic dermatitis animal studies research has been reported by scientists at Daejeon University, College of Oriental Medicine
Blood Pressure - New blood pressure data have been reported by scientists at Merck & Company, Inc.
Encephalitis Vaccines - Investigators at Intercell AG have published new data on encephalitis vaccines
Glioblastoma Therapy - Data from University of California, Department of Neurology advance knowledge in glioblastoma therapy
Head and Neck Cancer Therapy - Research from University of Texas, M.D. Anderson Cancer Center in the area of head and neck cancer therapy published
Life Sciences - New findings in life sciences described from University of Louisville
Lung Cancer Therapy - Study results from M.L. Liao and colleagues broaden understanding of lung cancer therapy
Monoclonal Antibodies - Reports summarize monoclonal antibodies study results from Dana-Farber Cancer Institute
Myeloma Therapy - Reports by J.D. Hainsworth and co-researchers describe recent advances in myeloma therapy
Affymax, Inc. - Affymax Reports Second Quarter 2008 Financial Results
AMAG Pharmaceuticals, Inc. - AMAG Pharmaceuticals Receives Fast Track Designation for Ferumoxytol for Vascular-Enhanced Magnetic Resonance Imaging
AMRI - AMRI Initiates Phase I Study of Proprietary Oncology Drug Candidate
Apoptosis - Aposense® [18f]-ml-10 To Be Radiolabelled By Iba for Multi-center Clinical Trials
Bristol-Myers Squibb Company - Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
Can-Fite BioPharma - Can-Fite BioPharma: Seikagaku Corporation, the Exclusive Licensee of CF101 in Japan, Is to Commence Phase I Clinical Trial in Japan With CF101 for the Treatment of Rheumatoid Arthritis
Cancer - Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
Cancer Vaccines - NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
Gout - Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
Hepatocellular Cancer - Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
HIV/AIDS - Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
Huntington Disease - XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
Kamada - Kamada Successfully Completes Phase II Trial with Aerosolized AAT in Cystic Fibrosis Patients
Logical Therapeutics, Inc. - Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
Non-Small Cell Lung Cancer - Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Prostate Cancer - FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011
Regeneron Pharmaceuticals, Inc. - Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration